Cathie Wood's ARK buys Teradyne, sells Coinbase and Robinhood stock

Cathie Wood's ARK ETFs strategically rebalanced their portfolio on July 10, 2025, making significant divestments from various tech and fintech holdings, including Coinbase, Robinhood, Roku, and Block. Concurrently, ARK made a substantial investment of over $16.6 million in Teradyne (TER), purchasing 179,242 shares, signaling a strong conviction in industrial automation and robotics. Smaller acquisitions in Tempus AI (TEM) further underscore a pivot towards AI-driven biotechnology, indicating ARK's evolving focus on these specific growth sectors.

Analysis

ARK Invest's trading activity on July 10, 2025, reveals a clear strategic portfolio rotation, reallocating capital from consumer technology and fintech into industrial automation and AI-driven biotechnology. The firm liquidated positions in Coinbase (COIN) for $6.2 million, Robinhood (HOOD) for $5.5 million, Roku (ROKU) for $5.6 million, and Block (XYZ) for $1.7 million, with the sales in COIN, ROKU, and Block noted as continuations of a multi-day trend. The capital was redeployed into a high-conviction purchase of 179,242 shares of Teradyne (TER) for $16.6 million, signaling a significant bet on the robotics and automation sector. This pivot is further supported by a smaller but notable follow-on investment of $950,739 in Tempus AI (TEM), reinforcing a growing interest in AI's application in healthcare. These moves collectively illustrate a deliberate shift in ARK's thematic focus, prioritizing industrial and enterprise AI over the previously favored fintech and crypto-adjacent assets. A cautionary note in the article mentions that an external AI analysis did not rank Teradyne as a top-valued stock, providing a counterpoint to ARK's bullish stance.

Key Decisions for Investors

• Investors should interpret ARK's consistent selling of COIN, HOOD, and ROKU as a potential bearish signal from a major growth-oriented fund, warranting a review of positions in these consumer-facing tech and fintech names.
• The substantial new investment in Teradyne (TER) signals strong institutional conviction in the industrial automation theme, making the stock a candidate for further due diligence for those looking to gain exposure to this sector.
• The accumulating position in Tempus AI (TEM) across multiple ARK funds, although smaller in dollar value, highlights emerging institutional interest in the AI-biotechnology space and merits monitoring.
• Despite the strong buy signal from ARK, the mention of a dissenting AI valuation on Teradyne suggests that investors should conduct their own independent valuation analysis rather than solely mirroring the trade.